HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor

Kovacs, Jeffrey J., Murphy, Patrick J.M., Gaillard, Stéphanie, Zhao, Xuan, Wu, June-Tai, Nicchitta, Christopher V., Yoshida, Minoru, Toft, David O. +2 more·2005·Molecular Cell
DOI 10.1016/j.molcel.2005.04.021

Cited by (1,001)

Items 701–800 of 1,001

  1. Targeting hsp90 family members: A strategy to improve cancer cell death
    Pedro Buc Calderón, Raphaël Beck, Christophe Glorieux · 2019 · Biochemical Pharmacology
  2. Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity
    Mark R. Woodford, Michael Hughes, Rebecca Sager, Sarah J. Backe, Alexander J. Baker-Williams, Michael S. Bratslavsky, Joseph M Jacob, Oleg Shapiro, Michael L. Wong, Gennady Bratslavsky et al. · 2019 · Oncotarget
  3. Exposure to a Histone Deacetylase Inhibitor Has Detrimental Effects on Human Lymphocyte Viability and Function
    Deborah J. L. Wong, Amol Rajeev Rao, Earl V Avramis, Douglas R. Matsunaga, Kimberly Mayumi Komatsubara, Mohammad S. Atefi, Helena Escuin-Ordinas, Thinle Chodon, Richard Chikara Koya, Antoni Ribas et al. · 2014 · Cancer Immunology Research
  4. Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells
    Kazunori Kageyama, Yasumasa Iwasaki, Yutaka Watanuki, Kanako Niioka, Makoto Daimon · 2021 · International Journal of Molecular Sciences
  5. Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection
    Yanan Sophia Zhang, Dazhuan Eric Xin, Zhizhang Wang, Wenlong Peng, Yuanyuan Zeng, Jianshu Liang, Mengmeng Xu, Nannan Chen, Jie Zhang, Jicheng Yue et al. · 2022 · Cell Death and Differentiation
  6. Design, Synthesis, and biological evaluation of HDAC6 inhibitors based on Cap modification strategy
    Xuedong Li, Xingang Liu, Songsong Wang, Xiaoxing Shi, Ming Lü, Xinyue Hao, Yan Fu, Yang Zhang, Qingzhong Jia, Dian He · 2022 · Bioorganic Chemistry
  7. (+)-Naloxone inhibits morphine-induced chemotaxis via prevention of heat shock protein 90 cleavage in microglia
    Ru‐Yin Tsai, Yu‐Che Cheng, Chih‐Shung Wong · 2015 · Journal of the Formosan Medical Association
  8. The primary cilium is a self-adaptable, integrating nexus for mechanical stimuli and cellular signaling
    An M. Nguyen, Yuan‐Nan Young, Christopher Rae Jacobs · 2015 · Biology Open
  9. Systematic identification of Class I HDAC substrates
    Tingting Li, B. Song, Z. Wu, Min Lu, Wei‐Guo Zhu · 2013 · Briefings in Bioinformatics
  10. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients
    Michaël Van Damme, Emerence Crompot, Nathalie Meuleman, Philippe Mineur, Barbara Dessars, Hakim El Housni, D Bron, Laurence Lagneaux, Basile Stamatopoulos · 2014 · Epigenetics
  11. Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
    Ning Ding, Lingyan Ping, Lixia Feng, Xiaohui Zheng, Yuqin Song, Jun Zhu · 2014 · Cancer Cell International
  12. Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
    Matthew W. Lawless, Suzanne Norris, Kenneth John O'Byrne, Steven G. Gray · 2009 · Endocrine Metabolic & Immune Disorders - Drug Targets
  13. Substrate specificity and function of acetylpolyamine amidohydrolases from Pseudomonas aeruginosa
    Andreas Krämer, Jan Herzer, Joerg Overhage, Franz‐Josef Meyer‐Almes · 2016 · BMC Biochemistry
  14. Honokiol from Magnolia spp. induces G1 arrest via disruption of EGFR stability through repressing HDAC6 deacetylated Hsp90 function in lung cancer cells
    Shiuan-Fu Liou, Kuo‐Tai Hua, Chia‐Yun Hsu, Meng‐Shih Weng · 2015 · Journal of Functional Foods
  15. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults
    Erik Koehne, Andrea Kreidenweiss, Rella Zoleko Manego, Matthew B. B. McCall, Ghyslain Mombo‐Ngoma, Marcel K. W. Mackwitz, Finn Kristian Hansen, Jana Held · 2019 · Scientific Reports
  16. Design and Synthesis of sEH/HDAC6 Dual-Targeting Inhibitors for the Treatment of Inflammatory Pain
    Huashen Xu, Yuanguang Chen, Hua Tong, Lu Chen, Christophe H.P. Morisseau, Zijian Zhou, Junning Zhuang, Chuqiao Song, Pengcheng Cai, Zhongbo Liu et al. · 2024 · Journal of Medicinal Chemistry
  17. An innovative approach to the treatment of Gaucher disease and possibly other metabolic disorders of the brain
    Roscoe O. Brady, Chunzhang Yang, Zhengping Zhuang · 2012 · Journal of Inherited Metabolic Disease
  18. The universe of Hsp90
    Marta Stankiewicz, Matthias P. Mayer · 2011 · BioMolecular Concepts
  19. Toxoplasma gondiiHsp90: potential roles in essential cellular processes of the parasite
    Sergio Oscar Angel, María J. Figueras, Maria Lis Alomar, Pablo C. Echeverría, Bin Deng · 2014 · Parasitology
  20. G protein-coupled receptor kinase 5 modifies cancer cell resistance to paclitaxel
    Joann Lagman, Paula Sayegh, Christina S. Lee, Sarah M. Sulon, Alec Z. Jacinto, Vanessa Sok, Natalie Peng, Deniz Alp, Jeffrey Benovic, Christopher H. So · 2019 · Molecular and Cellular Biochemistry
  21. Buxus alkaloid compound destabilizes mutant p53 through inhibition of the HSF1 chaperone axis
    Yuling Wang, Wei Wu, Yong-Nan Su, Zhipeng Ai, Han-Chuan Mou, Luo-Sheng Wan, Ying Luo, Ming‐Hua Qiu, Jihong Zhang · 2020 · Phytomedicine
  22. Comprehensive Analysis of the Differential Expression and Prognostic Value of Histone Deacetylases in Glioma
    Jinwei Li, Xianlei Yan, Cong Liang, Hongmou Chen, Meimei Liu, Zhikang Wu, Jiemin Zheng, Junsun Dang, Xiaojin La, Quan Liu · 2022 · Frontiers in Cell and Developmental Biology
  23. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model
    Ting Zhao, Yongqing Li, Baoling Liu, Baihong Pan, Xin Min Cheng, Patrick E. Georgoff, Hasan Badre Alam · 2015 · The Journal of Trauma: Injury, Infection, and Critical Care
  24. Glucocorticoid Resistance in Inflammatory Diseases
    Denis Paul Franchimont, George Panagiotis Chrousos · 2004 · CRC Press eBooks
  25. Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy
    Xiu Quan Gu, Hao Zhang, Min-Ru Jiao, Bo Ram Han, Zixue Zhang, Jianqi Li, Qingwei Zhang · 2021 · European Journal of Medicinal Chemistry
  26. Dysregulation of histone deacetylases in ocular diseases
    Jae Hyun Jun, Jun-Sik Kim, Leon F. Palomera, Dong‐Gyu Jo · 2023 · Archives of Pharmacal Research
  27. Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses
    Zhuang Li, Wenwen Xiao, Zhixiang Yang, Jiahui Guo, Junwei Zhou, Shaobo Xiao, Puxian Fang, Liurong Fang · 2024 · Journal of Virology
  28. Effect of EGF-Induced HDAC6 Activation on Corneal Epithelial Wound Healing
    Jie Wang, Andrew Lin, Luo Lu · 2010 · Investigative Ophthalmology & Visual Science
  29. Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
    Jasmine M. Zain · 2012 · Hematology/Oncology Clinics of North America
  30. 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors
    Riccardo Baruchello, Daniele Simoni, Paolo Marchetti, Riccardo Rondanin, Stefania Mangiola, Cristiana Costantini, Maria Meli, Giuseppe Giannini, Loredana Vesci, Valeria Carollo et al. · 2014 · European Journal of Medicinal Chemistry
  31. Loss of Elp3 Impairs the Acetylation and Distribution of Connexin-43 in the Developing Cerebral Cortex
    Sophie Laguesse, Pierre Close, Laura Van Hees, Alain Chariot, Brigitte Malgrange, Laurent Nguyen · 2017 · Frontiers in Cellular Neuroscience
  32. Pyridine hydroxamic acids are specific anti-HCV agents affecting HDAC6
    Maxim V. Kozlov, Alla A. Kleymenova, Lyudmila I. Romanova, Konstantin A. Konduktorov, Kamila A. Kamarova, Olga A. Smirnova, Vladimir Prassolov, Sergey N. Kochetkov · 2015 · Bioorganic & Medicinal Chemistry Letters
  33. Dopaminergic abnormalities in Hdac6-deficient mice
    Masahide Fukada, Atsuo Nakayama, Takayoshi Mamiya, Tso‐Pang Yao, Yoshiharu Kawaguchi · 2016 · Neuropharmacology
  34. HDAC6 promotes sepsis development by impairing PHB1-mediated mitochondrial respiratory chain function
    Shi-Dong Guo, Shengtao Yan, Wen Li, Hong Zhou, Jianping Yang, Yao Yao, Mei-Jia Shen, Liuwei Zhang, Hongbo Zhang, Li-Chao Sun · 2020 · Aging
  35. Epigenetic Metalloenzymes
    Christophe Blanquart, Camille Linot, Pierre‐François Cartron, Daniela Tomaselli, Antonello Mai, Philippe Bertrand · 2018 · Current Medicinal Chemistry
  36. In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods
    Abdullahi İbrahim Uba, Gökhan Zengin · 2023 · Amino Acids
  37. Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions
    Marco Cordani, Alessia Garufi, Rossella Benedetti, Marco Tafani, Michele Aventaggiato, Gabriella D’Orazi, Mara Cirone · 2024 · Biomolecules
  38. HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
    Michela Gottardi Zamperla, Barbara Illi, Veronica Barbi, Chiara Cencioni, Daniele Santoni, Stella Gagliardi, Maria Garofalo, Gabriele Antonio Zingale, Irene Pandino, Diego Sbardella et al. · 2024 · Clinical Epigenetics
  39. Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
    Kairui Yue, Simin Sun, Zequn Yin, Enqiang Liu, Geng Jia, Yuqi Jiang, Yajun Duan, Yuxin Chen, Xiaoyang Li · 2025 · Journal of Medicinal Chemistry
  40. Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer
    Younghee Park, Kyu Sang Lee, So Yeon Park, Jee Hyun Kim, Eun Young Kang, Sung Won Kim, Keon Young Eom, Kim Js, In Ah Kim · 2015 · Journal of Breast Cancer
  41. Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock
    Zhigang Chang, Yongqing Li, Wei He, Baoling Liu, Ihab F. Halaweish, Ted Bambakidis, Yingjian Liang, Hasan Badre Alam · 2015 · The Journal of Trauma: Injury, Infection, and Critical Care
  42. Polycystin‐1 dependent regulation of polycystin‐2 via GRP94, a member of HSP90 family that resides in the endoplasmic reticulum
    Qin Yao, Patricia Outeda, Hangxue Xu, Rebecca Walker, Denis Basquin, Feng Qian, Liudmila Cebotaru, Terry J. Watnick, Valeriu Cebotaru · 2021 · The FASEB Journal
  43. New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer
    Ferdinando Chiaradonna, Claudia Cirulli, Roberta Palorini, Giuseppina Votta, Lilia Alberghina · 2014 · Antioxidants and Redox Signaling
  44. HDAC inhibitors: applications in oncology and beyond
    Omika Katoch, Bilikeri S Dwarakanath, Paban K. Agrawala · 2013 · HOAJ Biology
  45. Dexamethasone Upregulates Nox1 Expression in Vascular Smooth Muscle Cells
    Daniel Siuda, Silke Tobias, Alma Rus, Ning Xia, Ulrich Förstermann, Huige Li · 2014 · Pharmacology
  46. Significant Enhancement of hPrx1 Chaperone Activity through Lysine Acetylation
    Yanchao Pan, Jinghua Jin, Yang Yu, Jiangyun Wang · 2014 · ChemBioChem
  47. TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function
    Jin Zhang, Enshun Xu, Xinbin Chen · 2013 · Journal of Biological Chemistry
  48. Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation
    Pablo C. Echeverría, Fedor Forafonov, Deo Prakash Pandey, Guillaume Mühlebach, Didier Picard · 2011 · BioData Mining
  49. To prevent neurodegeneration
    Guiping Du, Renjie Jiao · 2011 · Communicative & Integrative Biology
  50. A Miniaturized Glucocorticoid Receptor Translocation Assay Using Enzymatic Fragment Complementation Evaluated with qHTS
    Ping Zhu, Wei Zheng, Douglas S. Auld, Ajit Jadhav, Ryan MacArthur, Keith R. Olson, Kun Peng, Hyna Dotimas, Christopher P. Austin, James Inglese · 2008 · Combinatorial Chemistry & High Throughput Screening
  51. Advances in the Mechanistic Study of the Control of Oxidative Stress Injury by Modulating HDAC6 Activity
    Yuanye Xue, Bing Gan, Yanxing Zhou, Tingyu Wang, Tong Zhu, Xinsheng Peng, Xiangning Zhang, Yanfang Zhou · 2023 · Cell Biochemistry and Biophysics
  52. Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease
    Ting Liang, Shiru Liu, Baiyun Dang, Xiaofa Luan, Yifan Guo, Raphael R. Steimbach, Jiadong Hu, Long Lu, Peiyu Yue, Ruotian Wang et al. · 2024 · European Journal of Medicinal Chemistry
  53. Rationale for HDAC Inhibitor Therapy in Autoimmunity and Transplantation
    Wayne W. Hancock · 2011 · Handbook of experimental pharmacology
  54. Influence of Natural and Synthetic Histone Deacetylase Inhibitors on Chromatin
    Paul Vincent Licciardi, Faith A. A. Kwa, Katherine Ververis, Natasha Di Costanzo, Aneta Balcerczyk, Mimi L.K. Tang, Assam El‐Osta, Tom C. Karagiannis · 2012 · Antioxidants and Redox Signaling
  55. Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates
    Julia K. Varga, Kelsey Diffley, Katherine Welker Leng, Carol A. Fierke, Ora Schueler‐Furman · 2022 · Scientific Reports
  56. Heme-Dependent Activation of Neuronal Nitric Oxide Synthase by Cytosol Is Due to an Hsp70-Dependent, Thioredoxin-Mediated Thiol–Disulfide Interchange in the Heme/Substrate Binding Cleft
    Yoshihiro Morishima, Miranda Lau, Hwei‐Ming Peng, Yoshinari Miyata, Jason E. Gestwicki, William B. Pratt, Yoichi Osawa · 2011 · Biochemistry
  57. Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation
    Yue Zhang, Chang‐Mei Liu, Xian-cao Cao, Yi Zang, Yubo Zhou, Jia Xuan Li · 2014 · Biochemical and Biophysical Research Communications
  58. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells
    Pratikkumar Vekaria, Amar Kumar, Dharmalingam Subramaniam, Neil Dunavin, Anusha Vallurupalli, Frank J. Schoenen, Siddhartha Ganguly, Shrikant Anant, Joseph P. McGuirk, Roy A. Jensen et al. · 2019 · Leukemia
  59. Assays for pharmacodynamic analysis of histone deacetylase inhibitors
    Eun Joo Chung, Min-Jung Lee, Sunmin Lee, Jane B. Trepel · 2006 · Expert Opinion on Drug Metabolism & Toxicology
  60. Renal ciliopathies: promising drug targets and prospects for clinical trials
    Laura Alice Devlin, Praveen Dhondurao Sudhindar, John Andrew Sayer · 2023 · Expert Opinion on Therapeutic Targets
  61. HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression
    Fan Yang, Rui Sun, Zeng Hou, Fang-Lin Zhang, Yi Xiao, Yun‐Song Yang, Shao‐Ying Yang, Yifan Xie, Yingying Liu, Cheng Luo et al. · 2022 · Clinical and Translational Medicine
  62. Modulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
    Ana C. Liberman, María Antunica-Noguerol, EDUARDO S. ARZT · 2014 · Nuclear Receptor Research
  63. Beyond Androgen Deprivation
    Mark Frederick McCarty, Jalal Hejazi, Reza Rastmanesh · 2014 · Integrative Cancer Therapies
  64. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia
    Sara Ota, Zi-Qiang Zhou, Megan P. Romero, Guang Yang, Peter J. Hurlin · 2016 · Human Molecular Genetics
  65. Chapter 21 Recent Advances in the Medicinal Chemistry of Histone Deacetylase Inhibitors
    Dominic E. A. Brittain, Hilmar Weinmann, Eckhard Ottow · 2007 · Annual reports in medicinal chemistry
  66. Requirement of a novel splicing variant of human histone deacetylase 6 for TGF-β1-mediated gene activation
    Yan Zhuang, Hong T. Nguyen, Joseph A. Lasky, Subing Cao, Cui Li, Jiyao Hu, Xinyue Guo, Matthew E. Burow, Bin Shan · 2010 · Biochemical and Biophysical Research Communications
  67. Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
    Ciara Tierney, Despina Bazou, Muntasir Mamun Majumder, Pekka M. Anttila, Raija Helena Silvennoinen, Caroline Akemi Heckman, Paul Dowling, Peter O’Gorman · 2021 · Scientific Reports
  68. Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
    Yekatarina Gadasheva, Alexander Nolze, Claudia Großmann · 2021 · Frontiers in Molecular Biosciences
  69. Effects of the Glucocorticoid-Mediated Mitochondrial Translocation of Glucocorticoid Receptors on Oxidative Stress and Pyroptosis in BV-2 Microglia
    Ruonan Dang, Xuyang Hou, Xinglan Huang, Caifeng Huang, Xiaoqing Zhao, Xingrong Wang, Ning Zhang, Yuqi Yang, Nan Li, Sheng Liu et al. · 2024 · Journal of Molecular Neuroscience
  70. A novel insight into neurological disorders through HDAC6 protein–protein interactions
    Nasim Bahram Sangani, Jarno Koetsier, Jonathan Mélius, Martina Kutmon, Friederike Ehrhart, Chris T. Evelo, Leopold Curfs, Chris P.M. Reutelingsperger, Lars Eijssen · 2024 · Scientific Reports
  71. Decoding post-translational modification for understanding stress tolerance in plant
    Anuradha Pandey, Dipak Gayen · 2024 · Crop Design
  72. HDAC6 regulates thermogenesis of brown adipocytes through activating PKA to induce UCP1 expression
    Suna Jung, Miae Han, Sovannarith Korm, Se-in Lee, Solhee Noh, Sophors Phorl, Rema Naskar, Kye‐Sung Lee, Geon‐Hee Kim, Yun-Jaie Choi et al. · 2018 · Biochemical and Biophysical Research Communications
  73. Low-dose radiation differentially regulates protein acetylation and histone deacetylase expression in human coronary artery endothelial cells
    Žarko Barjaktarović, Juliane Merl‐Pham, Omid Azimzadeh, Stefan J. Kempf, Ken Raj, Michael John Atkinson, Soile Tapio · 2016 · International Journal of Radiation Biology
  74. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
    Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou · 2019 · Toxicology Letters
  75. 5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market
    Matthias Körner, Ulrich Tibes · 2008 · Progress in medicinal chemistry
  76. Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.
    T. B. Deb, Christine M. Coticchia, Robert J. Barndt, Hong Zuo, R. Dickson, M. Johnson · 2008 · American Journal of Physiology - Cell Physiology
  77. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation
    Anthea Hardcastle, Peter Tomlin, Clair Norris, Juliet Richards, Matthew Cordwell, Katherine J. Boxall, Martin Rowlands, Keith Jones, Ian Collins, Edward McDonald et al. · 2007 · Molecular Cancer Therapeutics
  78. Influenza A virus RNA localisation and the interceding trafficking pathways of the host cell
    Stefano Bonazza, David Courtney · 2025 · PLoS Pathogens
  79. Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes
    Pedro de Sena Murteira Pinheiro, Luan Pereira Diniz, Lucas Silva Franco, Michele Siqueira, Flávia Carvalho Alcântara Gomes · 2025 · Pharmaceuticals
  80. Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination
    Lucile Hoch, Nathalie Bourg, Fanny Degrugillier, Céline Bruge, Manon Benabidès, Emilie Pellier, Johana Tournois, Gurvan Mahé, Nicolas Maignan, Jack Dawe et al. · 2022 · Frontiers in Pharmacology
  81. Syntheses and Discovery of a Novel Class of Cinnamic Hydroxamates as Histone Deacetylase Inhibitors by Multimodality Molecular Imaging in Living Subjects
    Carmel T. Chan, Jun Qi, W. Smith, R. Paranol, Ralph Mazitschek, Nathan H. West, Robert E. Reeves, Gabriela Chiosis, Stuart L. Schreiber, James E. Bradner et al. · 2014 · Cancer Research
  82. Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model
    Ting Zhao, Yongqing Li, Baoling Liu, Ihab F. Halaweish, Ralph Mazitschek, Hasan Badre Alam · 2014 · Journal of Surgical Research
  83. Class II HDACs and Neuronal Regeneration
    Bor Luen Tang · 2014 · Journal of Cellular Biochemistry
  84. Discovery of a series of small molecules as potent histone deacetylase inhibitors
    Lei Zhang, Xuejian Wang, Xiaoguang Li, Wenfang Xu · 2013 · Journal of Enzyme Inhibition and Medicinal Chemistry
  85. Histone deacetylase inhibitors: can we consider potent anti-neoplastic agents for the treatment of asthma?
    Simon G. Royce, Katherine Ververis, Tom C. Karagiannis · 2012 · PubMed
  86. Repurposing of Hdac Inhibitors Toward Anti-Hepatitis C Virus Drug Discovery: Teaching an Old Dog New Tricks
    Fabao Zhao, Na Liu, Peng Zhan, Xinyong Liu · 2015 · Future Medicinal Chemistry
  87. Combination Strategies to Enhance the Potency of Monocyte-Derived Dendritic Cell-Based Cancer Vaccines
    Ronald J. Fecek, Walter J. Storkus · 2016 · Immunotherapy
  88. Stress Resistance Screen in a Human Primary Cell Line Identifies Small Molecules That Affect Aging Pathways and Extend Caenorhabditis elegans ’ Lifespan
    Peichuan Zhang, Yuying Zhai, James M. Cregg, Kenny K. H. Ang, Michelle R. Arkin, Cynthia J. Kenyon · 2019 · G3 Genes Genomes Genetics
  89. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis -Regulatory Landscape Exploitable in ER+ Breast Cancer
    Justin M. Craig, Tia H. Turner, Joshua Chuck Harrell, Charles V. Clevenger · 2021 · Endocrinology
  90. A Role for Histone Deacetylases in the Biology and Treatment of Post-Traumatic Stress Disorder: What Do We Know and Where Do We Go from Here?
    Robin E. Bonomi, Matthew J. Girgenti, John Harrison Krystal, Kelly Cosgrove · 2022 · Complex Psychiatry
  91. New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
    Abhijit M. Godbole, Vincent C.O. Njar · 2011 · Prostate Cancer
  92. Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line
    Masumeh Sanaei, Fraidoon Kavoosi · 2019 · Asian Pacific Journal of Cancer Prevention
  93. Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer
    Andrea Citarella, Silvia Belluti, Davide Bonanni, Davide Moi, Isabella Piccinini, Arianna Rinaldi, Chiara Papulino, Rosaria Benedetti, Laura Cuoghi, Stefano Di Ciolo et al. · 2025 · Journal of Medicinal Chemistry
  94. Functional stratification of cancer drugs through integrated network similarity
    Şeyma Ünsal Beyge, Nurcan Tunçbağ · 2022 · npj Systems Biology and Applications
  95. A quantitative model for virus uncoating predicts influenza A infectivity
    Alina V. Artcibasova, Longlong Wang, Stéphanie Anchisi, Yohei Yamauchi, Mirco Schmolke, Patrick Matthias, Jörg Stelling · 2023 · Cell Reports
  96. Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein–Protein Interactions
    Leen Asaad, Benjamin Pepperrell, Emma M. McErlean, Fiona M. Furlong · 2025 · International Journal of Molecular Sciences
  97. Advances in mechanisms of resistance to aromatase inhibitors
    Saranya Chumsri, Amanda J. Schech, Chakkapong Chakkabat, Gauri J. Sabnis, Angela M. H. Brodie · 2014 · Expert Review of Anticancer Therapy
  98. Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins
    Jessica A. Engel, Emma L. Norris, Paul R. Gilson, Jude M. Przyborski, Addmore Shonhai, Gregory L. Blatch, Tina S. Skinner‐Adams, Jeffrey John Gorman, Madeleine J. Headlam, Katherine T. Andrews · 2019 · Experimental Parasitology
  99. Role of the Bombyx mori nucleopolyhedrovirus LEF3 acetylation on viral replication
    Xu Gao, Jihai Lei, Yajie Zhu, Xi Chen, Fuxiang Mao, Meng Miao, Yanping Quan, Wei Yu · 2021 · Microbial Pathogenesis
  100. Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 Inhibitors
    Kosuke Hashimoto, Soichiro Ide, Mayumi Arata, Akiko Nakata, Akihiro Ito, Takashi K. Ito, Norio Kudo, Bangzhong Lin, Kazuto Nunomura, Keiko Tsuganezawa et al. · 2022 · ACS Medicinal Chemistry Letters